Consumer Product Safety
Viewpoints
Filter by:
Breaking: CPSC Obtains Record $15.45 Million Civil Penalty in Settlement Agreement with Gree
March 25, 2016 | Blog
This morning, the U.S. Consumer Product Safety Commission (CPSC) announced that it has obtained a record-breaking $15.45 million civil penalty in a settlement agreement with Gree Electric Appliances of China, Hong Kong Gree Electric Appliances Sales Co. of Hong Kong, and Gree USA Sales of California (Gree) over dehumidifiers sold under 13 different brand names.
Read more
Federal Court Makes No Exceptions for “Commodity Products” and Orders Zen Magnets to Stop Selling Previously Recalled Magnets
March 23, 2016 | Blog
There have been many twists and turns over the past four years concerning the CPSC’s regulation of certain high powered, rare-earth magnet sets and its litigation against various entities selling these magnets.
Read more
Lawsuits Against The Honest Company Highlight Continued Risks of "All Natural" Labeling
March 22, 2016 | Blog | By Lyzzette Bullock
Allegations are increasing against The Honest Company, Inc. for false and misleading marketing of its products as "all natural" and "plant-based" when they supposedly contain synthetic ingredients.The Honest Company sells personal care, cleaning, and baby products in multiple channels including at retail, online and through consumer subscriptions.
Read more
Fraudulent Dietary Supplements Highlighted in the 2016 National Consumer Protection Week
March 17, 2016 | Blog | By Joanne Hawana
In case you hadn’t heard about it or didn’t get involved in any of the events hosted by various campaign members, the week of March 6-12 was National Consumer Protection Week.
Read more
Health Canada Assesses Monetary Penalties against Company under Canadian Product Safety Act for First Time
March 14, 2016 | Blog | By Charles Samuels
On March 11, Health Canada announced that it had assessed administrative monetary penalties under the Canada Consumer Product Safety Act (CCPSA) against company Orange TKO Industries (Orange TKO or the Company) of Calgary.
Read more
Another California Dismissal of Proposed Class Action Regarding Disclosure of Forced Labor in the Supply Chain
March 7, 2016 | Blog | By Lyzzette Bullock
We recently blogged about a new wave of class action litigation related to California’s Transparency in Supply Chains Act. In December, Nestlé USA won the dismissal of a complaint against it alleging that the company was “obligated to inform consumers that some proportion of its cat food products may include seafood which was sourced from forced labor.”
Read more
Agencies Engaged in Federal Biotech Overhaul to Host Final Two Public Sessions in March
February 28, 2016 | Blog | By Joanne Hawana
After hosting the first of three stakeholder meetings late last year, federal government agencies engaged in overhauling the 1986 Coordinated Framework for the Regulation of Biotechnology recently announced that meetings two and three will take place on March 9 and March 30 in Dallas, Texas and Davis, California, respectively.
Read more
New GE Ingredient Labeling Bill Intensifies Food Fight in Congress
February 26, 2016 | Blog | By Sam Rothbloom
The latest salvo in the legislative food fight over genetically engineered (GE) ingredients came from the Senate, where Agriculture Committee Chairman Pat Roberts (R-KS) has introduced a bill that would instruct the Secretary of Agriculture to create a voluntary food labeling standard for bioengineered foods.
Read more
CPSC Adopts Mohorovic’s $250 Million Burden Relief Proposal for Adult Apparel
February 24, 2016 | Blog | By Charles Samuels
Earlier today, the CPSC unanimously agreed to publish in the Federal Register a new enforcement policy proposed by Commissioner Joe Mohorovic regarding the certification of certain adult wearing apparel (click here for policy-related materials and statement prepared by Commissioner Mohorovic).
Read more
Preemption Defense in the Ninth Circuit Is “Not Dead Yet”
February 19, 2016 | Blog | By Daniel Herling
Monty Python and the Holy Grail (1975) contained a scene where bodies of plague victims were brought out to the curb for collection via a cart whether or not they properly belonged there. One living fellow insists on not being dead by exclaiming: “I’m not dead yet.” Unfortunately for him, his protestations go unheeded and he is placed in the cart of the dead.
Read more
Federal Rule 68 Loophole; Not So Fast, My Friend.
February 17, 2016 | Blog | By Lyzzette Bullock
As we recently blogged about, in January the U.S. Supreme Court rejected the Rule 68 ‘pick off’ strategy in its Campbell-Edwald decision.
Read more
Reminder – Truthful Advertising Is Not Optional
February 12, 2016 | Blog | By Joanne Hawana
We blog frequently about new regulatory developments coming from CPSC or FDA and about enforcement actions brought by those federal agencies as well as state counterparts and private plaintiffs.
Read more
CPSC Public Database: An Important 2011 Change to the Procedure for Filing Materially Inaccurate Information Claims Can Easily be Overlooked
February 9, 2016 | Blog
President Obama signed Public Law 112-28 (“PL 112-28”) into law on August 12, 2011. PL 112-28 amended numerous provisions of the Consumer Product Safety Improvement Act (“CPSIA”). One such amendment made a notable change to the operation of the CPSC’s Saferproducts.gov database with respect to claims that a database report contains materially inaccurate information (“MII Claims”).
Read more
Class Action Defense Pick-Off Strategy Shot Down by SCOTUS
February 5, 2016 | Blog | By Lyzzette Bullock
Our colleagues Michael Arnold and Gauri Punjabi recently discussed the U.S. Supreme Court’s rejection of the Federal Rule 68 "pick off" strategy on Mintz Levin’s Employment Matters Blog.
Read more
FDA Places Ban on Import of GE Salmon
February 4, 2016 | Blog | By Katherine Fox
Reversing course from the end of 2015, FDA recently announced an import ban on genetically engineered (GE) salmon until such a time as comprehensive labeling guidelines are introduced.
Read more
"Just Mayo" Maker Convinces FDA That a Different Label Doesn't Have to Include a Different Name
January 20, 2016 | Blog | By Joanne Hawana
Back in September we blogged about the Warning Letter that FDA issued to Hampton Creek Foods, Inc. for its vegan food dressing and sandwich spread, “Just Mayo” and a similar product, “Just Mayo Sriracha.”
Read more
Confirmation of New FDA Head May Be Held Up By GE Salmon Labeling Issues
January 14, 2016 | Blog | By Joanne Hawana
On Tuesday, the Senate Health, Education, Labor, and Pensions (HELP) Committee unanimously approved the President's nomination of Dr. Robert Califf as the next commissioner of food and drugs.
Read more
Update: Albany County Legislature Amends Controversial Toxic Toys Law
January 13, 2016 | Blog
Last year, we wrote about a growing trend of local jurisdictions regulating children’s products, primarily toys and apparel. One such jurisdiction, Albany County, NY, enacted a far-reaching ordinance, “Local Law J of 2014,” that prohibited the sale of children’s products containing seven chemicals of “high concern” (see previous blog post here).
Read more
CPSC Launches New Portal to Guide Companies through Regulatory Maze
January 7, 2016 | Blog
Has your business experienced difficulty identifying on the CPSC’s website which product safety regulations are potentially applicable to your products?
Read more
Knockout in Round One: Court Dismisses California Supply Chains Act Class Action
December 29, 2015 | Blog | By Daniel Herling
The first round goes to the industry: on December 9, 2015, the Central District of California dismissed the complaint in Barber v. Nestle USA, a key bellwether case in a new wave of class action litigation related to California’s Transparency in Supply Chains Act.
Read more
Explore Other Viewpoints:
- AI: The Washington Report
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Cannabis
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Corporate Governance (ESG)
- Cross-Border Asset Recovery
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment
- Energy & Sustainability
- Environmental (ESG)
- Environmental Enforcement Defense
- Environmental Law
- Environmental, Social, and Corporate Governance (ESG)
- FDA Regulatory
- False Claims Act
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Impacts of a New US Administration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Pharmacy Benefits and PBM Contracting
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Probate & Fiduciary Litigation
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Social (ESG)
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- State Attorneys General
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Value-Based Care
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology